Butorphanol Tartrate Nasal Spray for Post-Cesarean Analgesia and Prolactin Secretion
Medical Science Monitor · 2024
DOI: 10.12659/msm.945224 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Medical Science Monitor, 2024. Verfasst von Jingzheng Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The General Hospital of Western Theater Command, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Butorphanol, Cesarean Section, Prolactin, Postoperative Pain. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
- Department of Gynecology and Obstetrics, The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Zitieren
APA
Zeng, J., Sun, X., Luo, M., Rao, Y., & Gong, G. (2024). Butorphanol Tartrate Nasal Spray for Post-Cesarean Analgesia and Prolactin Secretion. Medical Science Monitor. https://doi.org/10.12659/msm.945224
Vancouver
Zeng J, Sun X, Luo M, Rao Y, Gong G. Butorphanol Tartrate Nasal Spray for Post-Cesarean Analgesia and Prolactin Secretion. Medical Science Monitor. 2024. doi:10.12659/msm.945224
BibTeX
@article{Zeng2024,
author = {Zeng, Jingzheng and Sun, Xiaoqin and Luo, Mingyan and Rao, Yunju and Gong, Gu},
title = {Butorphanol Tartrate Nasal Spray for Post-Cesarean Analgesia and Prolactin Secretion},
journal = {Medical Science Monitor},
year = {2024},
doi = {10.12659/msm.945224}
}
EUVIMED